Therapeutic advances targeting tumor angiogenesis in pancreatic cancer: Current dilemmas and future directions

• Published in: Biochimica et biophysica acta. Reviews on cancer Vol. 1878; no. 5; p. 188958
• Main Authors: An, Yan-Fei, Pu, Ning, Jia, Jin-Bin, Wang, Wen-Quan, Liu, Liang
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2023
• Subjects: Angiogenesis; Anti-angiogenic therapy; Humans; Immunotherapy; Neovascularization, Pathologic - drug therapy; Pancreatic cancer; Pancreatic Neoplasms; Pancreatic Neoplasms - pathology; TME reprogramming; Tumor Microenvironment; Vascular remodeling; MVI; PFKFB3; CTLs; PNET; PARP; LAPC; CXCL2; SASP; HK2; ldCil; Vascular remodeling; Angiogenesis; IFP; HIF-2; CAFs; ECs; TAMs; GLUT-1; S1PR1; TGF-β; PFS; RFS; Hh; OS; FGF; VEGF; Tregs; ANG2; HGF; MMP2; HMGA1; IL-35; TME; EMT; ICI; LMWH; Anti-angiogenic therapy; PC; LOX; Pancreatic cancer; PSCs; PDGF; SBRT; HA; MVD; PD1; TME reprogramming; GAPDH
• ISSN: 0304-419X; 1879-2561; 1879-2561
• DOI: 10.1016/j.bbcan.2023.188958

Pancreatic cancer (PC) is one of the most lethal malignancies, which is generally resistant to various treatments. Tumor angiogenesis is deemed to be a pivotal rate-determining step for tumor growth and metastasis. Therefore, anti-angiogenetic therapy is a rational strategy to treat various cancers. However, numerous clinical trials on anti-angiogenetic therapies for PC are overwhelmingly disappointing. The unique characteristics of tumor blood vessels in PC, which are desperately lacking and highly compressed by the dense desmoplastic stroma, are reconsidered to explore some optimized strategies. In this review, we mainly focus on its specific characteristics of tumor blood vessels, discuss the current dilemmas of anti-angiogenic therapy in PC and their underlying mechanisms. Furthermore, we point out the future directions, including remodeling the abnormal vasculature or even reshaping the whole tumor microenvironment in which they are embedded to improve tumor microcirculation, and then create therapeutic vulnerabilities to the current available therapeutic strategies.